We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

New ‘Droplet Battery’ Could Power Next-Generation Wearable Devices and Implants

By HospiMedica International staff writers
Posted on 05 Sep 2023

Small bio-integrated devices with the capability to interact with and stimulate cells have potential therapeutic applications, including targeted drug delivery and faster wound healing. More...

However, these devices require a power source to function. Until now, finding an efficient method for providing power at the microscale has been a challenge. Scientists have now developed a miniature power source that can alter the activity of cultured human nerve cells. Drawing inspiration from how electric eels generate electricity, this device employs internal ion gradients to generate energy.

Researchers at University of Oxford (Oxford, UK) have created a miniaturized soft power source that works by depositing a sequence of five nanoliter-sized droplets of a conductive hydrogel (a 3D network of polymer chains infused with a significant amount of water). Each droplet possesses a distinct composition, generating a salt concentration gradient across the chain. These droplets are separated by lipid bilayers, which provide structural support while preventing ions from moving between the droplets. The power source becomes active when the structure is cooled to 4°C and the surrounding medium is changed. This disrupts the lipid bilayers and causes the droplets to merge into a continuous hydrogel. This allows ions to travel through the conductive hydrogel, from the high-salt droplets at the ends to the low-salt droplet in the center. Connecting the end droplets to electrodes converts the energy released from the ion gradients into electricity, enabling the hydrogel structure to serve as a power source for external components.

In the study, the activated droplet power source produced a sustained current for over 30 minutes. A unit comprising 50 nanoliter droplets yielded a maximum output power of around 65 nanowatts (nW). The devices maintained similar current levels even after 36 hours of storage. The research team then demonstrated how living cells could be attached to the device, allowing their activity to be directly regulated by the ionic current. Human neural progenitor cells stained with a fluorescent dye were connected to the device. When the power source was activated, time-lapse recording exhibited waves of intercellular calcium signaling in the neurons, induced by the local ionic current. According to the researchers, the device's modular design could facilitate the combination of multiple units to enhance generated voltage and/or current. This potential advancement could pave the way for powering next-generation wearable devices, bio-hybrid interfaces, implants, synthetic tissues, and microrobots. By linking 20 sets of five-droplet units in series, the researchers were able to illuminate a light-emitting diode requiring approximately 2 Volts. They envision that automating device production, such as using a droplet printer, could result in droplet networks comprised of thousands of power units.

“This work addresses the important question of how stimulation produced by soft, biocompatible devices can be coupled with living cells. The potential impact on devices including bio-hybrid interfaces, implants, and microrobots is substantial,” said Professor Hagan Bayley from the Department of Chemistry at University of Oxford, who was the research group leader for the study.

Related Links:
University of Oxford 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Pediatric Mask
Respire SOFT
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.